KRYS vs REGN: Which Stock is Better?
Side-by-side comparison of Krystal Biotech Inc and Regeneron Pharmaceuticals Inc in 2026
KRYS
Krystal Biotech Inc
$270.00
REGN
Regeneron Pharmaceuticals Inc
$755.51
Key Metrics Comparison
| Metric | KRYS | REGN | Winner |
|---|---|---|---|
| Market Cap | $7.87B | $78.92B | REGN |
| P/E Ratio | 39.04 | 17.99 | REGN |
| EPS (TTM) | $6.85 | $41.50 | REGN |
| Revenue Growth | 0.2% | 0.0% | KRYS |
| Gross Margin | 94.1% | 44.6% | KRYS |
Analyze KRYS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KRYS or REGN a better investment?
Comparing KRYS and REGN: Krystal Biotech Inc has a market cap of $7.87B while Regeneron Pharmaceuticals Inc has $78.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KRYS and REGN?
KRYS (Krystal Biotech Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KRYS or REGN?
Based on P/E ratios, REGN trades at a lower multiple (18.0x vs 39.0x).
Which is growing faster: KRYS or REGN?
KRYS has higher revenue growth at 0.2% vs 0.0% for REGN.
Which company is more profitable: KRYS or REGN?
Krystal Biotech Inc (KRYS) has higher gross margins at 94.1% compared to 44.6% for REGN.
Which is the larger company: KRYS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.92B compared to $7.87B for KRYS.
Should I buy KRYS or REGN in 2026?
Both KRYS and REGN have investment merit. KRYS trades at $270.00 while REGN trades at $755.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KRYS and REGN stock?
Key differences: Market Cap ($7.87B vs $78.92B), P/E Ratio (39.0x vs 18.0x), Revenue Growth (0.2% vs 0.0%), Gross Margin (94.1% vs 44.6%).